Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 RU 486.

× No keyword cloud information.

11 in total

Review 1. Molecular mechanism of RU 486 action: a review.

Authors: J Mao; W Regelson; M Kalimi
Journal: Mol Cell Biochem Date: 1992-01-15 Impact factor: 3.396

2. Selective effects of 8-Br-cAMP on agonists and antagonists of the glucocorticoid receptor.

Authors: S Zhang; M Danielsen
Journal: Endocrine Date: 1995-01 Impact factor: 3.633

3. PXR mediates mifepristone-induced hepatomegaly in mice.

Authors: Xin-Peng Yao; Ting-Ying Jiao; Yi-Ming Jiang; Shi-Cheng Fan; Ying-Yuan Zhao; Xiao Yang; Yue Gao; Fei Li; Yan-Ying Zhou; Pan-Pan Chen; Min Huang; Hui-Chang Bi
Journal: Acta Pharmacol Sin Date: 2021-03-29 Impact factor: 6.150

Review 4. Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors: R N Brogden; K L Goa; D Faulds
Journal: Drugs Date: 1993-03 Impact factor: 9.546

5. Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile.

Authors: Jeffrey N Miner; Bob Ardecky; Khalid Benbatoul; Kimberly Griffiths; Christopher J Larson; Dale E Mais; Keith Marschke; Jon Rosen; Eric Vajda; Lin Zhi; Andres Negro-Vilar
Journal: Proc Natl Acad Sci U S A Date: 2007-11-21 Impact factor: 11.205

10. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.

Authors: J Y Chen; S Penco; J Ostrowski; P Balaguer; M Pons; J E Starrett; P Reczek; P Chambon; H Gronemeyer
Journal: EMBO J Date: 1995-03-15 Impact factor: 11.598

RU 486.

Review 1. Molecular mechanism of RU 486 action: a review.

2. Selective effects of 8-Br-cAMP on agonists and antagonists of the glucocorticoid receptor.

3. PXR mediates mifepristone-induced hepatomegaly in mice.

Review 4. Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

5. Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile.

Review 6. Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.

7. Interaction of newly synthesized antiprogesterone ZK98299 with progesterone receptor from human myometrium.

8. AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation.

9. The many lives of mifepristone: Multi-glandular exaptation of an endocrine molecule.

10. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.